Published in AIDS Weekly, March 20th, 2000
Scientists have devised for the first time an HIV vaccine using a weakened rabies virus to carry a piece of the HIV "coat" into a cell. In rousing the body into making anti-HIV antibodies, they may have found a way to effectively turn on the immune system against the virus. The work, which for now is limited to tests in mice, lends hope to eventually designing such a vaccine against HIV in humans.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.